These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23512153)

  • 1. A novel biomimetic analysis system for quantitative characterisation of sclerosing foams used for the treatment of varicose veins.
    Carugo D; Ankrett DN; O'Byrne V; Willis S; Wright DD; Lewis AL; Hill M; Zhang X
    J Mater Sci Mater Med; 2013 Jun; 24(6):1417-23. PubMed ID: 23512153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foam-in-Vein: Characterisation of Blood Displacement Efficacy of Liquid Sclerosing Foams.
    Meghdadi A; Jones SA; Patel VA; Lewis AL; Millar TM; Carugo D
    Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.
    Star P; Connor DE; Parsi K
    Phlebology; 2018 Apr; 33(3):150-162. PubMed ID: 28166694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new automated system for the preparation of sclerosant foam: A study of the physical characteristics produced and the device settings required.
    Roche E; Pons R; Roche O; Puig A
    Phlebology; 2020 Oct; 35(9):724-733. PubMed ID: 32635818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sulodexide on stability of sclerosing foams.
    Critello CD; Fiorillo AS; Cristiano MC; de Franciscis S; Serra R
    Phlebology; 2019 Apr; 34(3):191-200. PubMed ID: 29871533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.
    Carugo D; Ankrett DN; Zhao X; Zhang X; Hill M; O'Byrne V; Hoad J; Arif M; Wright DD; Lewis AL
    Phlebology; 2016 May; 31(4):283-95. PubMed ID: 26036246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation and optimisation of foams for varicose vein sclerotherapy.
    Roberts TG; Cox SJ; Lewis AL; Jones SA
    Biorheology; 2020; 57(2-4):77-85. PubMed ID: 33459690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of clinically-relevant parameters on the cohesiveness of sclerosing foams in a biomimetic vein model.
    Carugo D; Ankrett DN; O'Byrne V; Wright DD; Lewis AL; Hill M; Zhang X
    J Mater Sci Mater Med; 2015 Nov; 26(11):258. PubMed ID: 26449448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.
    Rao J; Goldman MP
    Dermatol Surg; 2005 Jan; 31(1):19-22. PubMed ID: 15720090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.
    Hamel-Desnos C; Desnos P; Wollmann JC; Ouvry P; Mako S; Allaert FA
    Dermatol Surg; 2003 Dec; 29(12):1170-5; discussion 1175. PubMed ID: 14725657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of polidocanol foam in view of its use in sclerotherapy.
    Nastasa V; Samaras K; Ampatzidis Ch; Karapantsios TD; Trelles MA; Moreno-Moraga J; Smarandache A; Pascu ML
    Int J Pharm; 2015 Jan; 478(2):588-96. PubMed ID: 25433198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.
    Bai T; Liu Y; Jiang W; Li Y; Liu J; Yu C; Fan Y
    Dermatol Surg; 2020 Feb; 46(2):249-257. PubMed ID: 31569112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation on the influence of glycerin on sclerosant foam stability.
    Peterson JD; Goldman MP
    Phlebology; 2011 Sep; 26(6):232-4. PubMed ID: 21415429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size of Sclerosing Foams Prepared by Ultrasound, Mechanical Agitation, and the Handmade Tessari Method for Treatment of Varicose Veins.
    Critello CD; Fiorillo AS; Matula TJ
    J Ultrasound Med; 2017 Mar; 36(3):649-658. PubMed ID: 28127790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerosant foam structure and stability is strongly influenced by liquid air fraction.
    Cameron E; Chen T; Connor DE; Behnia M; Parsi K
    Eur J Vasc Endovasc Surg; 2013 Oct; 46(4):488-94. PubMed ID: 23993276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Tessari Tourbillon technique for making foam sclerotherapy with silicone-free syringes.
    Whiteley MS; Patel SB
    Phlebology; 2015 Oct; 30(9):614-7. PubMed ID: 25288590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfoam sclerotherapy.
    Redondo P; Cabrera J
    Semin Cutan Med Surg; 2005 Dec; 24(4):175-83. PubMed ID: 16387261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerotherapy and foam sclerotherapy for varicose veins.
    Coleridge Smith P
    Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation into the influence of various gases and concentrations of sclerosants on foam stability.
    Peterson JD; Goldman MP
    Dermatol Surg; 2011 Jan; 37(1):12-7. PubMed ID: 21199095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.